Largest pharmaceuticals by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 61 pharmaceuticals ranked by earnings, at AED 98.4B, ahead of Eli Lilly (AED 75.8B) and Merck & Co (AED 67B). Figures as of 18 Nov 2026, 15:14 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonAED 98.4B
- Median
- AED 216.7M
- Combined market value
- AED 18.79T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | AED 98.4B | AED 2.44T | AED 1,015.45 | 0.80% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | AED 75.8B | AED 4.58T | AED 5,144.23 | 1.06% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | AED 67B | AED 1.28T | AED 517.29 | 1.76% down | 51% up | ||
| 4 | Novo NordiskNVO · Health Care | AED 55.8B | AED 648.8B | AED 147.21 | 1.53% down | 17% down | ||
| 5 | NovartisNVS · Health Care | AED 51.4B | AED 1.09T | AED 575.65 | 1.51% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | AED 37.6B | AED 1.02T | AED 660.46 | 1.34% down | 2% up | ||
| 7 | SanofiSNY · Health Care | AED 31.8B | AED 418.3B | AED 174.19 | 0.22% down | 4% down | ||
| 8 | PfizerPFE · Health Care | AED 28.5B | AED 592.8B | AED 104.00 | 0.54% down | 14% up | ||
| 9 | GSKGSK · Health Care | AED 27.9B | AED 361.4B | AED 180.30 | 0.30% down | 6% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | AED 25.9B | AED 453B | AED 221.60 | 1.65% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | AED 24B | AED 665.3B | AED 384.15 | 0.11% down | 17% down | ||
| 12 | Regeneron PharmaceuticalsREGN · Health Care | AED 16.5B | AED 366.3B | AED 3,540.69 | 0.65% up | 36% up | ||
| 13 | AbbVieABBV · Health Care | AED 15.5B | AED 1.88T | AED 1,063.79 | 1.09% down | 26% up | ||
| 14 | Vertex PharmaceuticalsVRTX · Health Care | AED 14.5B | AED 501.5B | AED 1,978.04 | 0.81% up | 27% up | ||
| 15 | ZoetisZTS · Health Care | AED 9.8B | AED 124.8B | AED 307.20 | 0.19% up | 29% down | ||
| 16 | Teva Pharmaceutical IndustriesTEVA · Health Care | AED 5.2B | AED 182.3B | AED 156.25 | 0.19% down | 74% up | ||
| 17 | United TherapeuticsUTHR · Health Care | AED 4.9B | AED 90.3B | AED 2,121.28 | 1.12% down | 23% up | ||
| 18 | GenmabGMAB · Health Care | AED 3.5B | AED 117.1B | AED 189.94 | 0.47% down | 70% up | ||
| 19 | Royalty PharmaRPRX · Health Care | AED 2.8B | AED 145B | AED 252.14 | 0.04% down | 78% up | ||
| 20 | PTC TherapeuticsPTCT · Health Care | AED 2.5B | AED 18.6B | AED 222.83 | 0.51% up | 20% down | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | AED 1.7B | AED 45.9B | AED 55.11 | 1.39% up | 5% up | ||
| 22 | TG TherapeuticsTGTX · Health Care | AED 1.6B | AED 35.3B | AED 233.41 | 1.34% up | 107% up | ||
| 23 | GrifolsGRFS · Health Care | AED 1.6B | AED 21.4B | AED 31.50 | 0.63% down | 1% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | AED 1.3B | AED 42.5B | AED 219.53 | 2.15% up | 11% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | AED 1.2B | AED 76.2B | AED 568.97 | 1.02% down | 66% down | ||
| 26 | BeOne MedicinesONC · Health Care | AED 1.1B | AED 170.7B | AED 1,494.35 | 1.55% down | 17% up | ||
| 27 | AlkermesALKS · Health Care | AED 887.6M | AED 28.4B | AED 169.27 | 1.40% up | 58% up | ||
| 28 | Ligand PharmaceuticalsLGND · Health Care | AED 457.1M | AED 21.9B | AED 1,096.97 | 1.65% up | 43% up | ||
| 29 | Corcept TherapeuticsCORT · Health Care | AED 366M | AED 28B | AED 255.96 | 0.54% down | 8% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | AED 264.7M | AED 27.5B | AED 79.00 | 1.85% up | 83% up | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | AED 216.7M | AED 27.9B | AED 354.47 | 1.47% up | 126% up | ||
| 32 | Arrowhead PharmaceuticalsARWR · Health Care | -AED 6M | AED 22.7B | AED 160.54 | 1.67% up | 10% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | -AED 85.8M | AED 22B | AED 336.40 | 0.39% down | 31% up | ||
| 34 | Travere TherapeuticsTVTX · Health Care | -AED 93.8M | AED 17.8B | AED 185.70 | 1.06% down | 44% up | ||
| 35 | VeradermicsMANE · Health Care | -AED 257.1M | AED 19.6B | AED 464.29 | 0.61% up | 233% up | ||
| 36 | Belite BioBLTE · Health Care | -AED 285.1M | AED 23.7B | AED 582.58 | 0.57% up | 31% up | ||
| 37 | Oruka TherapeuticsORKA · Health Care | -AED 387.2M | AED 24.4B | AED 359.32 | 1.57% up | 241% up | ||
| 38 | ErascaERAS · Health Care | -AED 457.4M | AED 17.4B | AED 49.57 | 2.84% down | 403% up | ||
| 39 | Protagonist TherapeuticsPTGX · Health Care | -AED 478M | AED 30.4B | AED 466.35 | 1.84% up | 46% up | ||
| 40 | Spyre TherapeuticsSYRE · Health Care | -AED 570M | AED 33.4B | AED 352.05 | 2.17% up | 286% up | ||
| 41 | Dianthus TherapeuticsDNTH · Health Care | -AED 596.2M | AED 18.1B | AED 321.14 | 0.52% up | 113% up | ||
| 42 | Edgewise TherapeuticsEWTX · Health Care | -AED 616.3M | AED 16.7B | AED 152.98 | 0.93% down | 88% up | ||
| 43 | Axsome TherapeuticsAXSM · Health Care | -AED 672.8M | AED 26B | AED 494.56 | 0.96% down | 7% down | ||
| 44 | Definium TherapeuticsDFTX · Health Care | -AED 675.1M | AED 14.7B | AED 107.58 | 0.31% down | 169% up | ||
| 45 | Rhythm PharmaceuticalsRYTM · Health Care | -AED 721.9M | AED 29.9B | AED 430.76 | 0.57% up | 13% up | ||
| 46 | Elanco Animal HealthELAN · Health Care | -AED 852.1M | AED 48.3B | AED 96.73 | 1.88% up | 20% up | ||
| 47 | Ascendis PharmaASND · Health Care | -AED 929.3M | AED 64.9B | AED 989.68 | 0.64% down | 28% up | ||
| 48 | Madrigal PharmaceuticalsMDGL · Health Care | -AED 1.1B | AED 35.5B | AED 1,529.40 | 1.32% down | 24% down | ||
| 49 | Legend BiotechLEGN · Health Care | -AED 1.1B | AED 11.6B | AED 60.00 | 1.40% up | 42% down | ||
| 50 | Roivant SciencesROIV · Health Care | -AED 1.1B | AED 103.6B | AED 143.02 | 0.59% up | 90% up | ||
| 51 | Praxis Precision MedicinesPRAX · Health Care | -AED 1.1B | AED 31.7B | AED 1,132.47 | 1.07% up | 61% up | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -AED 1.2B | AED 18.3B | AED 105.27 | 2.91% up | 20% down | ||
| 53 | Jazz PharmaceuticalsJAZZ · Health Care | -AED 1.3B | AED 57.3B | AED 892.59 | 0.96% up | 37% up | ||
| 54 | ABIVAXABVX · Health Care | -AED 1.4B | AED 27B | AED 308.67 | 2.36% up | 27% down | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | -AED 1.4B | AED 16.5B | AED 99.32 | 0.30% up | 64% down | ||
| 56 | BridgeBio PharmaBBIO · Health Care | -AED 2.7B | AED 55.6B | AED 285.16 | 1.09% up | 17% up | ||
| 57 | CytokineticsCYTK · Health Care | -AED 2.9B | AED 26.7B | AED 191.69 | 1.05% up | 20% down | ||
| 58 | Takeda PharmaceuticalTAK · Health Care | -AED 3.5B | AED 251.9B | AED 78.84 | 0.80% down | 54% up | ||
| 59 | Summit TherapeuticsSMMT · Health Care | -AED 4B | AED 32.7B | AED 40.84 | 4.22% up | 36% down | ||
| 60 | InsmedINSM · Health Care | -AED 4.7B | AED 97.5B | AED 444.66 | 0.65% down | 40% down | ||
| 61 | ViatrisVTRS · Health Care | -AED 12.9B | AED 86.8B | AED 75.74 | 0.83% up | 96% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6729 AED).
Questions and answers
Which pharmaceuticals rank first by earnings?
Johnson & Johnson (AED 98.4B), Eli Lilly (AED 75.8B) and Merck & Co (AED 67B) are the top three of the 61 pharmaceuticals ranked by earnings as of 18 Nov 2026, 15:14 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by earnings.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by earnings have a combined market value of AED 18.79T as of 18 Nov 2026, 15:14 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceuticals by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.